ARS Investment Partners, LLC - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 67 filers reported holding REDHILL BIOPHARMA LTD in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARS Investment Partners, LLC ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q3 2021$240,000
-61.4%
52,495
-41.9%
0.02%
-61.9%
Q2 2021$621,000
-3.4%
90,333
+2.8%
0.06%
-16.0%
Q1 2021$643,000
+2.4%
87,837
+13.0%
0.08%
-2.6%
Q4 2020$628,000
+4.7%
77,714
+32.5%
0.08%
-18.1%
Q3 2020$600,00058,6640.09%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q1 2021
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 367,346$926,0000.15%
DISCIPLINED GROWTH INVESTORS INC /MN 1,950,002$4,914,0000.11%
Claret Asset Management Corp 95,430$240,0000.05%
Annandale Capital, LLC 43,532$110,0000.04%
ARK Investment Management 861,798$2,172,0000.01%
Virtu Financial LLC 26,864$68,0000.01%
Ancora Advisors LLC 82,048$207,0000.01%
OSAIC HOLDINGS, INC. 4,600$1,372,0000.00%
TWO SIGMA SECURITIES, LLC 25,499$64,0000.00%
ATTICUS WEALTH MANAGEMENT, LLC 2,425$6,0000.00%
View complete list of REDHILL BIOPHARMA LTD shareholders